abstract |
A method of inhibiting melanoma comprising administering to a human in need thereof an effective amount of a compound having the formulan wherein R 1 and R 3 are independently hydrogen, -CH 3 ,n orn wherein Ar is optionally substituted phenyl; n R 2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino, or a pharmaceutically acceptable salt of solvate thereof; alone or in combination with one or more melanoma-inhibiting agents. |